Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check5 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check55 days agoChange DetectedThe page has been updated to reflect a new version number, changing from v2.15.0 to v2.15.2, and the phrasing regarding the last update has been clarified.SummaryDifference0.1%
- Check63 days agoChange DetectedThe webpage has been updated to reflect a new phase 2 study involving Ipilimumab and Nivolumab for treating HPV-positive oropharyngeal carcinoma, with a new estimated last update date of April 2025.SummaryDifference2%
- Check70 days agoChange DetectedThe webpage has undergone significant updates, including the addition of detailed clinical stages and types of HPV-mediated oropharyngeal carcinoma, as well as the inclusion of a quality-of-life assessment and a new registry identifier. However, extensive information regarding the study's objectives, treatment protocols, and inclusion/exclusion criteria has been removed.SummaryDifference53%
Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.